Select M&A Deals and Terminations in the Age of Coronavirus

5/18/2020

Select M&A Deals and Terminations in the Age of Coronavirus

(Terms not announced unless specified)

  •     Beaver-Visitec Acquires Ophthalmic Viscoelastic Device Assets from Croma-Pharma (Austria)
  •     Smiths Medical Acquires Access Scientific (US)
  •     Zhuhai Baolian Asset Management Plans to Acquire Shanghai Kehua Bio-Engineering (China) -- Deal price -- $246.9m
  •     OncBioMune Pharma to Acquire Avant Diagnostics (US)
  •     Olink Proteomics Acquires Agrisera (Sweden)
  •     Safe Orthopaedics Plans to Acquire LCI MEDICAL (France)
  •     Cengiz Balcik and Yumnu Balcik Acquire Remaining 28% Stake in Yu-Ce Medical from Anatolia Growth Capital Fund (Turkey)
  •     Safeguard Medical Acquires Water-Jel Technologies (US)
  •     Aspen Surgical Acquires Precept Medical Products (US)
  •     Conventus Orthopaedics to Acquire Flower Orthopedics (US)
  •     Supernus Pharma to Acquire CNS Portfolio from US WorldMeds for $530m (US)
  •     Alphatec Terminates $121.9m Agreement to Acquire EOS Imaging, Due to COVID-19
  •     Ethicon Terminates $400m Acquisition of Tachosil from Takeda (Japan)
  •     AK Medical International to Acquire Beijing Libeier Biology for $40.2m (China)
  •     OrthoPediatrics Acquires ApiFix for $39.6m (Israel)
  •     NZ Bidco Terminates $189.6m Acquisition of Abano Healthcare (New Zealand)